Recent research suggests a possible increased risk of serious eye conditions, such as non-arteritic anterior ischaemic optic ...

The risk of new-onset diabetic retinopathy (DR) increased slightly, but significantly, in patients taking GLP-1 receptor ...

A popular drug used for diabetes and weight loss may also help protect the brain. That’s the key message from a new study ...

A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and ...

Researchers at the University of Utah say new weight loss drugs pose new questions about what happens to muscle mass and ...

Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which ...

A study has found that prescribing semaglutide in everyday clinical settings led to modest but meaningful improvements in cardiovascular risk alongside a rise in non-drug healthcare costs. The study, ...

The people who took semaglutide experienced a drop in their 10-year risk of developing atherosclerotic cardiovascular disease from 7.6% to 6.3% between the start of the study and the one-year mark ...

The road ahead As research into semaglutide’s effects on brain health continues, it is likely to open up new avenues for understanding and potentially treating Alzheimer’s disease.

Certain effects of semaglutide are already known to affect heart health directly, said Saad, who further pointed out that the drug “stabilizes atherosclerotic plaques, preventing the development ...

Xu and colleagues reported an association between semaglutide use and a lower risk for opioid overdose during a 1-year follow-up compared with other antidiabetic medications — which included ...